Graves SA[Author] - Search Results

Year	Number of Results
1974	2
1975	1
1976	1
1978	1
1980	2
1983	2
1985	5
1990	1
1994	1
1997	1
1998	1
2001	1
2003	2
2004	1
2014	1
2015	14
2016	15
2017	8
2018	3
2019	2
2020	3
2021	8
2022	8

1

Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.

England CG, Ehlerding EB, Hernandez R, Rekoske BT, Graves SA, Sun H, Liu G, McNeel DG, Barnhart TE, Cai W. England CG, et al. Among authors: graves sa. J Nucl Med. 2017 Jan;58(1):162-168. doi: 10.2967/jnumed.116.177857. Epub 2016 Aug 4. J Nucl Med. 2017. PMID: 27493273 Free PMC article.

2

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer.

Plichta KA, Graves SA, Buatti JM. Plichta KA, et al. Among authors: graves sa. Int J Mol Sci. 2021 Nov 9;22(22):12095. doi: 10.3390/ijms222212095. Int J Mol Sci. 2021. PMID: 34829977 Free PMC article. Review.

3

Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy.

Graves SA, Hobbs RF. Graves SA, et al. Semin Radiat Oncol. 2021 Jan;31(1):37-44. doi: 10.1016/j.semradonc.2020.07.008. Semin Radiat Oncol. 2021. PMID: 33246635 Review.

4

Radiopharmaceutical Chemistry and Drug Development-What's Changed?

Kunos CA, Mankoff DA, Schultz MK, Graves SA, Pryma DA. Kunos CA, et al. Among authors: graves sa. Semin Radiat Oncol. 2021 Jan;31(1):3-11. doi: 10.1016/j.semradonc.2020.07.006. Semin Radiat Oncol. 2021. PMID: 33246634 Free PMC article. Review.

5

Half-life of ⁵¹Mn.

Graves SA, Ellison PA, Valdovinos HF, Barnhart TE, Nickles RJ, Engle JW. Graves SA, et al. Phys Rev C. 2017 Jul;96(1):014613. doi: 10.1103/physrevc.96.014613. Epub 2017 Jul 18. Phys Rev C. 2017. PMID: 34327291 Free PMC article.

6

SIR-Spheres Activity Measurements Reveal Systematic Miscalibration.

Graves SA, Martin M, Tiwari A, Merrick M, Sunderland J. Graves SA, et al. J Nucl Med. 2022 Aug;63(8):1131-1135. doi: 10.2967/jnumed.121.262650. Epub 2022 Jan 6. J Nucl Med. 2022. PMID: 34992155

7

Imaging and dosimetric characteristics of ⁶⁷ Cu.

Merrick MJ, Rotsch DA, Tiwari A, Nolen J, Brossard T, Song J, Wadas TJ, Sunderland JJ, Graves SA. Merrick MJ, et al. Among authors: graves sa. Phys Med Biol. 2021 Jan 26;66(3):035002. doi: 10.1088/1361-6560/abca52. Phys Med Biol. 2021. PMID: 33496267

8

Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.

Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Sgouros G, et al. Among authors: graves sa. J Nucl Med. 2021 Dec;62(Suppl 3):12S-22S. doi: 10.2967/jnumed.121.262750. J Nucl Med. 2021. PMID: 34857617

9

Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns.

Wahl RL, Sgouros G, Iravani A, Jacene H, Pryma D, Saboury B, Capala J, Graves SA. Wahl RL, et al. Among authors: graves sa. J Nucl Med. 2021 Dec;62(Suppl 3):23S-35S. doi: 10.2967/jnumed.121.262751. J Nucl Med. 2021. PMID: 34857619 No abstract available.

10

Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources.

Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, Zimmerman BE. Capala J, et al. Among authors: graves sa. J Nucl Med. 2021 Dec;62(Suppl 3):3S-11S. doi: 10.2967/jnumed.121.262749. J Nucl Med. 2021. PMID: 34857621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results